Adicet Bio receives FDA fast track designation for its lupus erythematosus treatment
Source: SeekingAlpha
2025-02-05 08:44:21 ET
More on Adicet Bio
- Seeking Alpha’s Quant Rating on Adicet Bio
- Historical earnings data for Adicet Bio
- Financial information for Adicet Bio
Read the full article on Seeking Alpha
For further details see:
Adicet Bio receives FDA fast track designation for its lupus erythematosus treatment
Adicet Bio Inc.
NASDAQ: ACET
ACET Trading
0.78% G/L:
$7.2663 Last:
47,405 Volume:
$7.41 Open:
ACET Latest News
ACET Stock Data
$70,641,246
7,595,730
46.88%
30
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
